Idrapril

DB19598ExperimentalSmall molecule

Idrapril is a small molecule drug. The usage of the INN stem '-pril' in the name indicates that Idrapril is a angiotensin-converting enzyme inhibitor. Idrapril has a monoisotopic molecular weight...

Formula / weight: C₁₁H₁₈N₂O₅ · 258.274 g/mol (avg)

Resolves to

Compound

UNII176P5C4QU8CAS127420-24-0ChEMBLCHEMBL2104330

Structure

InChIKeyQKIVRALZQSUWHH-SFYZADRCSA-NSMILESCN(CC(=O)NO)C(=O)[C@@H]1CCCC[C@@H]1C(O)=O

Targets

P12821ACE

What you can answer from here — as of September 19, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with Idrapril, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account